Moloney Securities Asset Management, LLC Novartis Ag Transaction History
Moloney Securities Asset Management, LLC
- $706 Million
- Q4 2024
A detailed history of Moloney Securities Asset Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 3,861 shares of NVS stock, worth $413,088. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,861
Previous 3,486
10.76%
Holding current value
$413,088
Previous $400,000
6.25%
% of portfolio
0.05%
Previous 0.06%
Shares
29 transactions
Others Institutions Holding NVS
# of Institutions
1,446Shares Held
130MCall Options Held
1.12MPut Options Held
1.61M-
Dodge & Cox San Francisco, CA12.2MShares$1.31 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.18 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$866 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$747 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.58MShares$597 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...